Natera

These founders are revolutionizing pre-natal medicine

Leadership:
Matthew Rabinowitz
2016 Revenue:
$217 Million
Industry:
Health
Location:
San CarlosCA 
Founded:
2004
Patent score:
16
Natera co-founders CTO Johnathan Sheena, left, and CEO Matthew Rabinowitz. Photo Credit: Courtesy Company

This San Carlos, California-based biotech company makes non-invasive prenatal tests. Co-founder and CEO Matthew Rabinowitz saw his family devastated by the death of a baby with an untested genetic condition; he founded Natera to develop tests that can pick up on fetal chromosomal issues nine weeks into pregnancy. Natera's flagship test, known as an NIPT, analyzes traces of fetal cells that circulate in the mother's blood. Rabinowitz is tapping into a $665 million-plus global market of non-invasive prenatal testing, according to Persistence Market Research, and expanding: Natera hopes to unveil cancer diagnostics by the end of this year.

Other Inc. Honors

2016

MORE COMPANY INFORMATION

Website:
natera.com